SCHEMBL14153548

SCHEMBL14153548

C/N=C(\N)c1ccc(C#Cc2cccc(F)c2)cn1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 2/20 0.57
▸ CYP1A2 P05177 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14153545 0.88 GRM5 (0.55) GRM5
SCHEMBL15913884 0.88 GRM5 (0.55) GRM5
SCHEMBL14153156 0.78 MAP4K4 (0.44) —
SCHEMBL13388628 0.78 GRM5 (0.65) GRM5
SCHEMBL15649650 0.76 GRM5 (0.63) GRM5CYP1A2
SCHEMBL14838804 0.76 CYP1A2 (0.67) CYP1A2
SCHEMBL14061768 0.75 GRM5 (0.55) GRM5
SCHEMBL16465199 0.74 GRM5 (0.52) GRM5
SCHEMBL14838727 0.73 GRM5 (0.66) GRM5CYP1A2
SCHEMBL13388619 0.73 GRM5 (1.00) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162635-A1 METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2012-11-29 — — WO disclosed
Send feedback